Agenus Inc. (NASDAQ:AGEN) saw a downside of -1.22% to close Monday at $5.65 after subtracting -$0.07 on the day. The 5-day average trading volume is 3,858,000 shares of the company’s common stock. It has gained $5.86 in the past week. An average of 4,085,540 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 3,958,146.
AGEN’s 1-month performance is -13.08% or -$0.85 on its low of $5.12 reached on 10/01/21. The company’s shares have touched a 52-week low of $2.50 and high of $6.79, with the stock’s rally to the 52-week high happening on 08/30/21. YTD, AGEN has achieved 77.67% or $2.47. However, the current price is down -16.79%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Sep 13, 29 days have gone by since the last insider trading activity for Agenus Inc. (AGEN). ARMEN GARO H (Chairman and CEO) most recently sold 82,107 shares at $6.50 per share on Sep 13. This transaction cost the insider $533,696. PFO & PAO, KLASKIN CHRISTINE M, sold 11,120 shares at a price of $6.50 on Sep 10.
Agenus Inc. (AGEN) has a trailing price-to-earnings (P/E) ratio of 34.65 for the broader industry and 32.24 for the sector.AGEN stock has a beta of 1.28. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 19.29.
. In terms of profitability, the gross margin trailing 12 months is 94.90%. The trailing 12-month EBITDA margin is -323.16%. The firm’s gross profit as reported stood at $85.82 million against revenue of $88.17 million.
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected AGEN to announce -$0.24 per share in earnings in its latest quarter, but it posted -$0.37, representing a -54.20% surprise. EBITDA for the quarter stood at more than -$64.67 million. AGEN stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 448.05 million, with total debt at $56.85 million. Shareholders hold equity totaling $233.12 million
Let’s look briefly at Agenus Inc. (AGEN) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 11 October was 48.91% to suggest the stock is trending Neutral, with historical volatility in this time period at 22.05%.
The stock’s 5-day moving average is $5.68, reflecting a +3.29% or $0.18 change from its current price. AGEN is currently trading -11.02% above its 20-day SMA, +35.17% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by +9.07% and +62.36% respectively.
Stochastic %K and %D was 54.26% and 53.44% and the average true range (ATR) pointed at 0.25. The RSI (14) points at 47.87%, while the 14-day stochastic is at 49.30% with the period’s ATR at 0.26. The stock’s 9-day MACD Oscillator is pointing at 0.18 and 0.09 on the 14-day charts.
Analysts offering their rating for AGEN stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate AGEN as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 3 have offered a “buy” rating.
What is AGEN’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $8.00 and a high of $12.00, with their median price target at $10.00. Looking at these predictions, the average price target given by analysts is for Agenus Inc. (AGEN) stock is $10.00.